# Super Micro Computer, Inc.: financial statements, quarterly

SMCI · Nasdaq · CIK 1375365 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/smci.md) · [Financials](/companies/smci/financials.md) · [Filings](/companies/smci/filings.md) · [Insiders](/companies/smci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/smci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [2.1](/filings/0001375365-25-000005.md) | [3.7](/filings/0001375365-25-000006.md) | [3.9](/filings/0001375365-25-000014.md) | [5.4 d](/filings/0001375365-26-000022.md) | [5.9](/filings/0001375365-25-000030.md) | [5.7](/filings/0001375365-26-000007.md) | [4.6](/filings/0001375365-26-000014.md) | [5.8 d](/filings/0001375365-26-000022.md) | [5.0](/filings/0001375365-25-000030.md) | [12.7](/filings/0001375365-26-000007.md) | [10.2](/filings/0001375365-26-000014.md) | [11.1 d](/filings/0001375365-26-000022.md) |
| Cost of revenue | $bn | [1.8](/filings/0001375365-25-000005.md) | [3.1](/filings/0001375365-25-000006.md) | [3.3](/filings/0001375365-25-000014.md) | [4.8 d](/filings/0001375365-26-000022.md) | [5.2](/filings/0001375365-25-000030.md) | [5.0](/filings/0001375365-26-000007.md) | [4.2](/filings/0001375365-26-000014.md) | [5.2 d](/filings/0001375365-26-000022.md) | [4.6](/filings/0001375365-25-000030.md) | [11.9](/filings/0001375365-26-000007.md) | [9.2](/filings/0001375365-26-000014.md) | [9.2 d](/filings/0001375365-26-000022.md) |
| Gross profit | $bn | [0.4](/filings/0001375365-25-000005.md) | [0.6](/filings/0001375365-25-000006.md) | [0.6](/filings/0001375365-25-000014.md) | [0.5 d](/filings/0001375365-26-000022.md) | [0.8](/filings/0001375365-25-000030.md) | [0.7](/filings/0001375365-26-000007.md) | [0.4](/filings/0001375365-26-000014.md) | [0.5 d](/filings/0001375365-26-000022.md) | [0.5](/filings/0001375365-25-000030.md) | [0.8](/filings/0001375365-26-000007.md) | [1.0](/filings/0001375365-26-000014.md) | [1.9 d](/filings/0001375365-26-000022.md) |
| Research and development | $bn | [0.1](/filings/0001375365-25-000005.md) | [0.1](/filings/0001375365-25-000006.md) | [0.1](/filings/0001375365-25-000014.md) | [0.1 d](/filings/0001375365-26-000022.md) | [0.1](/filings/0001375365-25-000030.md) | [0.2](/filings/0001375365-26-000007.md) | [0.2](/filings/0001375365-26-000014.md) | [0.2 d](/filings/0001375365-26-000022.md) | [0.2](/filings/0001375365-25-000030.md) | [0.2](/filings/0001375365-26-000007.md) | [0.2](/filings/0001375365-26-000014.md) | [0.2 d](/filings/0001375365-26-000022.md) |
| Operating income | $bn | [0.2](/filings/0001375365-25-000005.md) | [0.4](/filings/0001375365-25-000006.md) | [0.4](/filings/0001375365-25-000014.md) | [0.3 d](/filings/0001375365-26-000022.md) | [0.5](/filings/0001375365-25-000030.md) | [0.4](/filings/0001375365-26-000007.md) | [0.1](/filings/0001375365-26-000014.md) | [0.2 d](/filings/0001375365-26-000022.md) | [0.2](/filings/0001375365-25-000030.md) | [0.5](/filings/0001375365-26-000007.md) | [0.6](/filings/0001375365-26-000014.md) | [1.5 d](/filings/0001375365-26-000022.md) |
| Interest expense | $bn | [0.0](/filings/0001375365-23-000041.md) | [0.0](/filings/0001375365-24-000011.md) | [0.0](/filings/0001375365-24-000022.md) | [0.0 d](/filings/0001375365-26-000022.md) | [0.0](/filings/0001375365-25-000030.md) | [0.0](/filings/0001375365-26-000007.md) | [0.0](/filings/0001375365-26-000014.md) | [0.0 d](/filings/0001375365-26-000022.md) | [0.0](/filings/0001375365-25-000030.md) | [0.0](/filings/0001375365-26-000007.md) | [0.1](/filings/0001375365-26-000014.md) | [0.1 d](/filings/0001375365-26-000022.md) |
| Income tax | $bn | [0.0](/filings/0001375365-25-000005.md) | [0.1](/filings/0001375365-25-000006.md) | [(0.0)](/filings/0001375365-25-000014.md) | [0.0 d](/filings/0001375365-26-000022.md) | [0.1](/filings/0001375365-25-000030.md) | [0.1](/filings/0001375365-26-000007.md) | [0.0](/filings/0001375365-26-000014.md) | [0.0 d](/filings/0001375365-26-000022.md) | [0.0](/filings/0001375365-25-000030.md) | [0.1](/filings/0001375365-26-000007.md) | [0.1](/filings/0001375365-26-000014.md) | [0.3 d](/filings/0001375365-26-000022.md) |
| Net income | $bn | [0.2](/filings/0001375365-25-000005.md) | [0.3](/filings/0001375365-25-000006.md) | [0.4](/filings/0001375365-25-000014.md) | [0.3 d](/filings/0001375365-26-000022.md) | [0.4](/filings/0001375365-25-000030.md) | [0.3](/filings/0001375365-26-000007.md) | [0.1](/filings/0001375365-26-000014.md) | [0.2 d](/filings/0001375365-26-000022.md) | [0.2](/filings/0001375365-25-000030.md) | [0.4](/filings/0001375365-26-000007.md) | [0.5](/filings/0001375365-26-000014.md) | [1.2 d](/filings/0001375365-26-000022.md) |
| Diluted EPS | $ per share | [0.27](/filings/0001375365-25-000005.md) | [0.51](/filings/0001375365-25-000006.md) | [0.66](/filings/0001375365-25-000014.md) | not reported | [0.67](/filings/0001375365-25-000030.md) | [0.51](/filings/0001375365-26-000007.md) | [0.17](/filings/0001375365-26-000014.md) | not reported | [0.26](/filings/0001375365-25-000030.md) | [0.60](/filings/0001375365-26-000007.md) | [0.72](/filings/0001375365-26-000014.md) | not reported |
| Basic EPS | $ per share | [0.30](/filings/0001375365-25-000005.md) | [0.55](/filings/0001375365-25-000006.md) | [0.71](/filings/0001375365-25-000014.md) | not reported | [0.72](/filings/0001375365-25-000030.md) | [0.54](/filings/0001375365-26-000007.md) | [0.18](/filings/0001375365-26-000014.md) | not reported | [0.28](/filings/0001375365-25-000030.md) | [0.67](/filings/0001375365-26-000007.md) | [0.81](/filings/0001375365-26-000014.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001375365-23-000041.md) | [0.7](/filings/0001375365-24-000011.md) | [2.1](/filings/0001375365-24-000022.md) | [1.7](/filings/0001375365-25-000027.md) | [2.1](/filings/0001375365-25-000005.md) | [1.4](/filings/0001375365-25-000006.md) | [2.5](/filings/0001375365-25-000014.md) | [5.2](/filings/0001375365-26-000022.md) | [4.2](/filings/0001375365-25-000030.md) | [4.1](/filings/0001375365-26-000007.md) | [1.3](/filings/0001375365-26-000014.md) | [7.5](/filings/0001375365-26-000022.md) |
| Current assets | $bn | [3.6](/filings/0001375365-23-000041.md) | [4.8](/filings/0001375365-24-000011.md) | [8.1](/filings/0001375365-24-000022.md) | [8.9](/filings/0001375365-25-000027.md) | [9.9](/filings/0001375365-25-000005.md) | [8.7](/filings/0001375365-25-000006.md) | [9.5](/filings/0001375365-25-000014.md) | [12.3](/filings/0001375365-26-000022.md) | [12.7](/filings/0001375365-25-000030.md) | [26.1](/filings/0001375365-26-000007.md) | [21.6](/filings/0001375365-26-000014.md) | [27.7](/filings/0001375365-26-000022.md) |
| Total assets | $bn | [4.1](/filings/0001375365-23-000041.md) | [5.4](/filings/0001375365-24-000011.md) | [8.9](/filings/0001375365-24-000022.md) | [9.8](/filings/0001375365-25-000027.md) | [10.9](/filings/0001375365-25-000005.md) | [9.7](/filings/0001375365-25-000006.md) | [10.7](/filings/0001375365-25-000014.md) | [14.0](/filings/0001375365-26-000022.md) | [14.4](/filings/0001375365-25-000030.md) | [28.0](/filings/0001375365-26-000007.md) | [23.5](/filings/0001375365-26-000014.md) | [29.9](/filings/0001375365-26-000022.md) |
| Current liabilities | $bn | [1.6](/filings/0001375365-23-000041.md) | [2.0](/filings/0001375365-24-000011.md) | [1.7](/filings/0001375365-24-000022.md) | [2.3](/filings/0001375365-25-000027.md) | [2.9](/filings/0001375365-25-000005.md) | [1.4](/filings/0001375365-25-000006.md) | [1.4](/filings/0001375365-25-000014.md) | [2.3](/filings/0001375365-26-000022.md) | [2.3](/filings/0001375365-25-000030.md) | [15.4](/filings/0001375365-26-000007.md) | [8.1](/filings/0001375365-26-000014.md) | [7.2](/filings/0001375365-26-000022.md) |
| Total liabilities | $bn | [1.9](/filings/0001375365-23-000041.md) | [2.3](/filings/0001375365-24-000011.md) | [3.8](/filings/0001375365-24-000022.md) | [4.4](/filings/0001375365-25-000027.md) | [5.0](/filings/0001375365-25-000005.md) | [3.5](/filings/0001375365-25-000006.md) | [4.4](/filings/0001375365-25-000014.md) | [7.7](/filings/0001375365-26-000022.md) | [7.9](/filings/0001375365-25-000030.md) | [21.0](/filings/0001375365-26-000007.md) | [15.9](/filings/0001375365-26-000014.md) | [15.5](/filings/0001375365-26-000022.md) |
| Long-term debt | $bn | [0.1](/filings/0001375365-23-000041.md) | [0.1](/filings/0001375365-24-000011.md) | [0.1](/filings/0001375365-24-000022.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.2](/filings/0001375365-23-000041.md) | [3.1](/filings/0001375365-24-000011.md) | [5.1](/filings/0001375365-24-000022.md) | [5.4](/filings/0001375365-25-000027.md) | [5.9](/filings/0001375365-25-000005.md) | [6.2](/filings/0001375365-25-000006.md) | [6.4](/filings/0001375365-25-000014.md) | [6.3](/filings/0001375365-26-000022.md) | [6.5](/filings/0001375365-25-000030.md) | [7.0](/filings/0001375365-26-000007.md) | [7.6](/filings/0001375365-26-000014.md) | [14.5](/filings/0001375365-26-000022.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [270](/filings/0001375365-25-000005.md) | [(595) d](/filings/0001375365-25-000006.md) | [(1,514) d](/filings/0001375365-25-000014.md) | [(648) d](/filings/0001375365-26-000022.md) | [409](/filings/0001375365-25-000030.md) | [(240) d](/filings/0001375365-26-000007.md) | [627 d](/filings/0001375365-26-000014.md) | [864 d](/filings/0001375365-26-000022.md) | [(918)](/filings/0001375365-25-000030.md) | [(23.9) d](/filings/0001375365-26-000007.md) | [(6,615) d](/filings/0001375365-26-000014.md) | [747 d](/filings/0001375365-26-000022.md) |
| Capital expenditure | $m | [2.6](/filings/0001375365-25-000005.md) | [14.7 d](/filings/0001375365-25-000006.md) | [92.9 d](/filings/0001375365-25-000014.md) | [14.0 d](/filings/0001375365-26-000022.md) | [44.3](/filings/0001375365-25-000030.md) | [27.5 d](/filings/0001375365-26-000007.md) | [32.7 d](/filings/0001375365-26-000014.md) | [22.7 d](/filings/0001375365-26-000022.md) | [32.3](/filings/0001375365-25-000030.md) | [21.2 d](/filings/0001375365-26-000007.md) | [80.3 d](/filings/0001375365-26-000014.md) | [28.2 d](/filings/0001375365-26-000022.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.0](/filings/0001375365-23-000041.md) | [56.1](/filings/0001375365-24-000011.md) | [56.2](/filings/0001375365-24-000022.md) | [572](/filings/0001375365-25-000005.md) | [581](/filings/0001375365-25-000006.md) | [614](/filings/0001375365-25-000014.md) | [639](/filings/0001375365-25-000030.md) | [636](/filings/0001375365-26-000007.md) | [622](/filings/0001375365-26-000014.md) | [663](/filings/0001375365-25-000030.md) | [694](/filings/0001375365-26-000007.md) | [692](/filings/0001375365-26-000014.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 656,965,384 at 2026-07-31, from the cover of the [10-K filed 2026-08-31](/filings/0001375365-26-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.